GoodRx Holdings, Inc. (GDRX) Total liabilities 2019–2025
GoodRx Holdings, Inc. (GDRX) total liabilities at each fiscal year-end, per SEC filings.
$787.8MFY2025 · since FY2019: $737.4M → $787.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $787.8M | +18.7% |
| FY2024 | $663.4M | -19.8% |
| FY2023 | $826.8M | +4.7% |
| FY2022 | $789.8M | +1.8% |
| FY2021 | $775.9M | +2.3% |
| FY2020 | $758.8M | +2.9% |
| FY2019 | $737.4M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More GDRX financial trends
GDRX RevenueGDRX Net incomeGDRX Net marginGDRX Gross profitGDRX Gross marginGDRX Operating incomeGDRX Operating marginGDRX Operating cash flowGDRX Free cash flowGDRX Capital expendituresGDRX Return on equityGDRX Stock buybacksGDRX Dividends paidGDRX Total assetsGDRX Shareholders’ equityGDRX overview →